Loading...
Semaglutide
India Pharmaceutical Trade Intelligence
Who Supplies Semaglutide to India from CHINA
India's semaglutide imports from CHINA total $3.9M across 23 shipments from 15 foreign suppliers. SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD leads with $2.9M in import value; the top 5 suppliers together control 95.2% of this origin. Leading Indian buyers include STELIS BIOPHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for semaglutide — a diversified sourcing base with multiple active suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD is the leading Semaglutide supplier from CHINA to India, with import value of $2.9M across 2 shipments. The top 5 suppliers — SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD, M/S SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD, HANGZHOU ZHONGMEIHUADONG PHARMACEUT, SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD, SINOPEP-ALLSINO BIOPHARMACEUTICAL — collectively account for 95.2% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD | $2.9M | 2 | 73.5% |
| 2 | M/S SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD | $489.1K | 1 | 12.5% |
| 3 | HANGZHOU ZHONGMEIHUADONG PHARMACEUT | $152.1K | 1 | 3.9% |
| 4 | SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD | $128.7K | 2 | 3.3% |
| 5 | SINOPEP-ALLSINO BIOPHARMACEUTICAL | $79.7K | 2 | 2.0% |
| 6 | SINOPEP-A11SINO BIOPHARMACEUTICAL | $69.0K | 1 | 1.8% |
| 7 | SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD | $26.0K | 2 | 0.7% |
| 8 | SINOPEP-ALLSINO BIOPHARMACEUTICAL CO. LIMITED | $24.0K | 1 | 0.6% |
| 9 | DR REDDYS LABORATORIES LIMITED | $16.2K | 1 | 0.4% |
| 10 | DR.REDDYS LABORATORIES LIMITED | $14.6K | 1 | 0.4% |
| 11 | SINOPEP ALLSINO BIOPHARMACEUTICAL C | $13.0K | 2 | 0.3% |
| 12 | BEIJING ZHONGGUANCUN INTEGRATED BIOTCH LTD | $9.7K | 1 | 0.2% |
| 13 | SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LIMITED | $9.0K | 2 | 0.2% |
| 14 | NINGBO MINDO PHARMACEUTICAL CO. LTD | $8.0K | 1 | 0.2% |
| 15 | WUHAN BIOLAB-REAGENT BIOTECHNOLOGY CO., LTD | $161 | 1 | 0.0% |
Showing top 15 of 15 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STELIS BIOPHARMA LIMITED | $2.9M | 2 | 73.5% |
| 2 | CHEMO INDIA FORMULATION PRIVATE LIMITED | $489.1K | 1 | 12.5% |
| 3 | ALKEM LABORATORIES LIMITED | $165.1K | 3 | 4.2% |
| 4 | NATCO PHARMA LIMITED | $152.7K | 3 | 3.9% |
| 5 | MANKIND PHARMA LIMITED | $148.8K | 4 | 3.8% |
| 6 | HETERO LABS LIMITED | $28.2K | 2 | 0.7% |
| 7 | DR REDDY S LABORATORIES LIMITED | $16.2K | 1 | 0.4% |
| 8 | DR.REDDY'S LABORATORIES LTD | $14.6K | 1 | 0.4% |
| 9 | BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED | $9.7K | 1 | 0.2% |
| 10 | HETERO DRUGS LIMITED | $8.0K | 1 | 0.2% |
| 11 | ARAGEN LIFE SCIENCES LIMITED | $6.8K | 1 | 0.2% |
| 12 | KRISHGEN BIOSYSTEMS | $161 | 1 | 0.0% |
| 13 | SOTAC PHARMACEUTICALS PRIVATE LIMITED | $128 | 1 | 0.0% |
| 14 | IMPERIAL LIFE SCIENCES PRIVATE LIMITED | $111 | 1 | 0.0% |
Import Statistics
- Import Value
- $3.9M
- Shipments
- 23
- Foreign Suppliers
- 15
- Indian Buyers
- 14
- Avg. Shipment
- $170.4K
Other Semaglutide Import Origins
Related Analysis
Frequently Asked Questions — Semaglutide Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Semaglutide suppliers from CHINA to India?
The top Semaglutide suppliers from CHINA to India include SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD, M/S SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD, HANGZHOU ZHONGMEIHUADONG PHARMACEUT. The leading supplier is SINOPEP - AIISINO BIOPHARMACEUTICAL CO., LTD with import value of $2.9M USD across 2 shipments. India imported Semaglutide worth $3.9M USD from CHINA in total across 23 shipments.
QHow much Semaglutide does India import from CHINA?
India imported Semaglutide worth $3.9M USD from CHINA across 23 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Semaglutide from CHINA?
The main Indian buyers of Semaglutide sourced from CHINA include STELIS BIOPHARMA LIMITED, CHEMO INDIA FORMULATION PRIVATE LIMITED, ALKEM LABORATORIES LIMITED. The largest buyer is STELIS BIOPHARMA LIMITED with $2.9M in imports across 2 shipments.
QWhat is the total value of Semaglutide imports from CHINA to India?
The total value of Semaglutide imports from CHINA to India is $3.9M USD, across 23 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Semaglutide.
- 2.Supplier/Buyer Matching: 15 foreign suppliers from CHINA and 14 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $3.9M aggregated from 23 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
15 suppliers, 14 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists